Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Tocris Bioscience™ Methoxyluteolin
Click to view available options
Quantity:
50 mg
Description
Methoxyluteolin inhibits release of pro-inflammatory mediators from mast cells and decreases gene expression and release of TNF, VEGF and IL-8/CXCL8. The product also significantly inhibits IL-33 stimulated expression and release of CCL5 and CCL2. Methoxyluteolin pretreatment of LAD2 mast cells decreases gene expression of TNF, CXCL8 and VEGF in response to neurotensin or substance P via mTOR activation.
Specifications
Specifications
Chemical Name or Material | 2-(3,4-Dimethoxyphenyl)-5,7-dimethoxy-4 H-1-benzopyran-4-one |
CAS | 855-97-0 |
Quantity | 50 mg |
Target | Cytokine Compounds |
Molecular Formula | C19H18O6 |
Purity | 0.98 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction